新的辅助治疗被广泛用于降低肝细胞肿瘤以及延缓肿瘤恶化，以减少在等待移植时死亡的病患人数。
Neoadjuvant therapies are widely used to downstage hepatocellular tumors and slow the progression of tumors so that fewer patients die while waiting for transplants.
该发现为研究和治疗癌症打开了了新思路：如果肿瘤的肝细胞可以被根除，那么它本身也会随即死去。
This opens new ways of thinking about and treating the cancers. If its stem cells are eradicated, the rest of a tumour may die off.
肝细胞癌(HCC)是最常见的恶性肿瘤之一，由于快速浸润性生长及合并肝硬化因此其预后不良。
Hepatocellular carcinoma (HCC) is one of the most common malignancies. It has a poor prognosis due to its rapid infiltrating growth and complicated liver cirrhosis.
应用推荐